Dynamic Action Potential Clamp Investigation of Pro-Arrhythmic Risk of Drugs Binding to hERG Potassium Channels  by Mann, Stefan A. & Vandenberg, Jamie I.
Tuesday, February 18, 2014 553aOur results demonstrated that the c.A2987T KCNH2 mutation is the primary
cause of the LQTS phenotype. Precise genetic modification of pluripotent
stem cells provided a physiologically and functionally relevant human cellular
context to reveal the pathogenic mechanism underlying this specific disease
phenotype.
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Many commonly used drugs can bind to and block the hERG channel and cause
the potentially life threatening acquired long-QT syndrome.
Whilst obtaining an IC50 for drug block of hERG is relatively straight forward,
this is a poor surrogate for risk of pro-arrhythmia. Predicting the overall conse-
quences of hERG drug block on cardiac electrical activity is complicated by the
fact that the effect of hERG channel block varies in different cells (e.g. epicar-
dial, mid-myocardial, endocardial, Purkinje) of the heart. Furthermore it is
significantly altered by the electrical remodeling that occurs in many chronic
heart conditions. With the aging of our population and an increasing proportion
of people with chronic heart conditions it is especially important to understand
how disease states affect the consequences of hERG drug block and risk of pro-
arrhythmia.
Here we describe a recently developed dynamic action potential clamp system
(dAPC) to investigate the effect of hERG block on cardiomyocytes. The system
consists of conventional whole cell voltage clamp study of ion channels in
mammalian expression systems, coupled to a real time computer model of
human cardiomyocyte action. The dAPC system integrates the current record-
ings from a patch clamped cell into an in-silico cell model, the output of which
is then used to determine the voltage of the patch clamped cell. When used in
combination with a state of the art drug perfusion system this integrative
approach will permit testing of drugs on specified ion channels in a physiolog-
ically relevant environment, something that is not possible with conventional
patch clamp methods.
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Mutations in calmodulin (CaM) cause long-QT syndrome and recurrent cardiac
arrest (Circulation (2013) 127: 1009). Arrhythmogenesis likely arises from
impaired CaM regulation of ion channels, especially Ca2þ-dependent inactiva-
tion (CDI) of L-type calcium channels (LTCCs). Yet, traditional assessment of
the Ca2þ sensitivity of CDI conflates channel gating (controlling Ca2þ influx),
and actual Ca2þ responsiveness of CDI. Here, we used Ca2þ-photouncaging to
deliver known Ca2þ steps to LTCCs. Liþ was the charge carrier to restrict the
source of Ca2þ to that uniformly photouncaged by UV flashes. Panel A displays
the CaM C-lobe component of CDI, isolated by coexpressing LTCCs with
mutant CaM12 (Ca
2þ binding only to C-lobe). Absent Ca2þ uncaging, quasi-
steady currents were evoked (black). Ca2þ uncaging induced strong and
kinetically resolved CDI (gray, with fit). Isolating the N-lobe form of CDI
(panel B) yielded a slower but also strong form of CDI. Data such as
these enabled full profiles of steady-
state and kinetic responsiveness of
CDI to Ca2þ. Intriguingly, disease-
related CaM mutations resulted in
well-resolved and specific deficits in
the Ca2þ-to-CDI response profile, offer-
ing powerful insight into the channel
mechanistic alterations that ultimately
yield system-level disease.2798-Pos Board B490
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INTRODUCTION: KATP channels are known to provide a functional linkage
between the electrical activity of cell membrane and metabolism. The KCNJ8-encoded Kir6.1 (KATP) channel is critical in the regulation of vascular tone
and cardiac adaptive response to systemic metabolic stressors, including sepsis.
Previously, we identified two KCNJ8 mutations (E332del and V346I) in a large
sudden infant death syndrome (SIDS) cohort that exhibited a marked loss-of-
function phenotype. Here we asked whether these SIDS mutations display
dominant-negative effects on co-expressed wild type (WT) and further examine
the mechanism underlying its abnormal channel function. METHODS AND
RESULTS: A hemagglutinin (HA) epitope was introduced in an extracellular
loop of Kir6.1-WT and mutations through recombinant PCR technique.
Kir6.1-WT and Kir6.1 mutant (E332del or V346I) were co-expressed heterol-
ogously with SUR2A in HEK293 cells for whole cell patch clamp recordings.
HA-tagged Kir6.1-WT and Kir6.1-E332del or V346I were co-expressed
heterologously with SUR2A in HEK293 cells for live cell western blot with
primary anti-HA antibody and the 2nd antibody labeled IRDye 800 and
detected by LI-COR Odyssey infrared imaging system and for quantification
of cell surface expression by flow-cytometry with FITC-conjugated anti-
HA antibody. Compared with Kir6.1-WT, pinacidil-activated KATP currents
for E332del and V346I were decreased 57% to 68% between 20 mV and
40 mV as reported previously in COS-1 cells. The live cell western analysis
showed that the intensities of the cell surface expression of Kir6.1-E332del
and V346I were 24% to 42% of Kir6.1-WT. The cell-counting studies by
flow-cytometry indicated that the cell surface expression of Kir6.1-WT was
suppressed 35% to 70% when co-expressed with Kir6.1-E332del or Kir6.1-
V346I in a 1:1 DNA ratio. CONCLUSION: The loss-of-functional Kir6.1
KATP channel mutations found in SIDS displayed a channel trafficking defect
to the plasma membrane and exerted the dominant-negative effect on Kir6.1-
WT channels.
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Background and rationale:
Until recently the study of dysfunctional ion channels in their native environ-
ment was only possible by using transgenic animal models, which do not
recapitulate human physiology. Here, we have investigated the use of hiPS-
CM’s as a model system for investigating cardiac channelopathies, specifically
long QT Syndrome-9 (LQT9) causing Cav3 mutation (F97C-Cav3).
Methods:
Commercially available hiPS-CM’s were obtained from Cellular Dynamic
International. hiPS-CM’s were infected with WT-Cav3 or F97C-Cav3 and
studied with standard patch-clamp techniques.
Results:
Using HEK293 cells and in rat myocytes we previously reported that
LQT9 causing mutations did not affect peak-sodium current (INa-P), but
increased late-sodium current (INa-L).
In the HEK293 heterologous cell system
we transfected the key components
nNOS, a1-syntrophin and WT-Cav3/
F97C-Cav3 to elucidate mechanism.
To investigate the use of hiPS-CM’s as
a model, we infected hiPS-CM’s with
WT-Cav3/F97C-Cav3. We report that,
INa-p was unchanged (A&B) but report
an increase in INa-L (C&D).
Conclusion:
hiPS-CM’s are a relevant physiologic
expression model system to study car-
diac channelopathies that recapitulates
the native environment of a human ven-
tricular myocyte.2800-Pos Board B492
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Introduction & Objective: Several lines of evidence suggest that cytokines
are potent mediators of cardiac remodelling including hypertrophy and
generation of reactive oxidative species (ROS). Increases in serum cytokines,
notably necrosis factor-alpha (TNFa) and interleukin-1b (IL-1b), have been
